ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer

Zhu, Weian; Wu, Jianjie; Huang, Jiongduan; Xiao, Dongming; Li, Fengao; Wu, Chenglun; Li, Xiaojuan; Zeng, Hengda; Zheng, Jiayu; Lai, Wenjie*; Wen, Xingqiao*安徽医科大学; 南方医科大学; 中山大学; 1
Frontiers in Immunology2023-4-14DOI: 10.3389/fimmu.2023.1122670
2被引8阅读
引用收藏
分享

摘要

IntroductionMacrophages are components of the innate immune system and can play an anti-tumor or pro-tumor role in the tumor microenvironment owing to their high heterogeneity and plasticity. Meanwhile, prostate cancer (PCa) is an immune-sensitive tumor, making it essential to investigate the value of macrophage-associated networks in its prognosis and treatment. MethodsMacrophage-related marker genes (MRMGs) were identified through the comprehensive analysis of single-cell sequencing data from GSE141445 and the impact of macrophages on PCa was evaluated using consensus clustering of MRMGs in the TCGA database. Subsequently, a macrophage-related marker gene prognostic signature (MRMGPS) was constructed by LASSO-Cox regression analysis and grouped based on the median risk score. The predictive ability of MRMGPS was verified by experiments, survival analysis, and nomogram in the TCGA cohort and GEO-Merged cohort. Additionally, immune landscape, genomic heterogeneity, tumor stemness, drug sensitivity, and molecular docking were conducted to explore the relationship between MRMGPS and the tumor immune microenvironment, therapeutic response, and drug selection. ResultsWe identified 307 MRMGs and verified that macrophages had a strong influence on the development and progression of PCa. Furthermore, we showed that the MRMGPS constructed with 9 genes and the predictive nomogram had excellent predictive ability in both the TCGA and GEO-Merged cohorts. More importantly, we also found the close relationship between MRMGPS and the tumor immune microenvironment, therapeutic response, and drug selection by multi-omics analysis. DiscussionOur study reveals the application value of MRMGPS in predicting the prognosis of PCa patients. It also provides a novel perspective and theoretical basis for immune research and drug choices for PCa.

学科与关键词

关键词
prostate cancermacrophage-related marker geneprognostic signaturetumor immunitygenomic heterogeneitydrug choicessingle-cell RNA-sequencing
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2023-04-14
卷期
第 14 卷
页码
1122670
DOI
10.3389/fimmu.2023.1122670
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81874095, 82072820]; Basic and Applied Basic Research Foundation of Guangdong Province [2019B1515120007, 2021A1515111210, 2023A1515010588]; National Natural Science Foundation Cultivation Project of Shenzhen Hospital of Southern Medical University [22H3AGZR09]

作者

  • Z

    Zhu, Weian (第一作者)

    sun yat sen univ

  • W

    Wu, Jianjie

    sun yat sen univ

查看全部 11 位作者收起作者
  • H

    Huang, Jiongduan

    sun yat sen univ

  • X

    Xiao, Dongming

    sun yat sen univ

  • L

    Li, Fengao

    1 · anhui med univ

  • W

    Wu, Chenglun

    sun yat sen univ

  • L

    Li, Xiaojuan

    southern med univ

  • Z

    Zeng, Hengda

    sun yat sen univ

  • Z

    Zheng, Jiayu

    sun yat sen univ

  • L

    Lai, Wenjie (通讯)

    sun yat sen univ

  • W

    Wen, Xingqiao (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417